ILMN - Illumina, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
314.52
-7.54 (-2.34%)
At close: 4:00PM EDT

314.95 +0.43 (0.14%)
After hours: 7:26PM EDT

Stock chart is not supported by your current browser
Previous Close322.06
Open321.96
Bid311.51 x 1200
Ask313.93 x 800
Day's Range314.00 - 322.44
52 Week Range226.62 - 372.61
Volume907,023
Avg. Volume951,508
Market Cap46.205B
Beta (3Y Monthly)1.44
PE Ratio (TTM)56.57
EPS (TTM)5.56
Earnings DateApr 25, 2019
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est340.54
Trade prices are not sourced from all markets
  • Everything You Need to Know About Investing in Healthcare
    Motley Fool7 hours ago

    Everything You Need to Know About Investing in Healthcare

    The global demand for healthcare products and services will keep growing significantly. Here's your complete guide to finding the best healthcare stocks and ETFs.

  • 3 Medical Product Stocks Set to Beat This Earnings Season
    Zacksyesterday

    3 Medical Product Stocks Set to Beat This Earnings Season

    The global medical device space takes significant strides in terms of research and development (R&D) and regulatory progress in the first quarter.

  • Illumina Reports Its Q1 Results on Thursday: 3 Things You Can Expect
    Motley Fool2 days ago

    Illumina Reports Its Q1 Results on Thursday: 3 Things You Can Expect

    The gene-sequencing pioneer isn't likely to hit a home run in Q1. But Illumina should run up the score later in 2019.

  • Pump the Brakes on the Illumina and Pacific Biosciences Deal
    Motley Fool4 days ago

    Pump the Brakes on the Illumina and Pacific Biosciences Deal

    The United Kingdom's Competition and Markets Authority has opened an investigation into the acquisition. What happens now?

  • Top Gene-Sequencing Stocks for 2019
    Motley Fool5 days ago

    Top Gene-Sequencing Stocks for 2019

    These next-generation companies are working on game-changing ways to obtain and profit from genetic insight.

  • 5 Top Healthcare Stocks to Buy in 2019
    Motley Fool5 days ago

    5 Top Healthcare Stocks to Buy in 2019

    Healthcare is hot, and these top healthcare stocks could be among the hottest of them all this year.

  • Are Insiders Selling Illumina, Inc. (NASDAQ:ILMN) Stock?
    Simply Wall St.5 days ago

    Are Insiders Selling Illumina, Inc. (NASDAQ:ILMN) Stock?

    We've lost count of how many times insiders have accumulated shares in a company that goes on to improve markedly. The flip side of that is that there are more than a few examples of insiders dumping stock prior to a period of weak perf...

  • Analysts Estimate Illumina (ILMN) to Report a Decline in Earnings: What to Look Out for
    Zacks6 days ago

    Analysts Estimate Illumina (ILMN) to Report a Decline in Earnings: What to Look Out for

    Illumina (ILMN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

  • 3 Top Healthcare Stocks to Buy in April
    Motley Fool8 days ago

    3 Top Healthcare Stocks to Buy in April

    GW Pharmaceuticals, Illumina, and Intercept Pharmaceuticals could all be great buys this month.

  • Will Solid Consumables Drive Illumina's (ILMN) Q1 Earnings?
    Zacks9 days ago

    Will Solid Consumables Drive Illumina's (ILMN) Q1 Earnings?

    Despite ongoing customers' transition from HiSeq consumables to NovaSeq, Illumina's (ILMN) Q1 results are expected to gain from this high throughput suite.

  • ETF Trends9 days ago

    Four Companies Could Power The New Genomics ETF

    Earlier this week, the Global X Genomics & Biotechnology ETF (Nasdaq: GNOM) debuted, giving investors a new avenue for tapping the fast-growing genomics market. GNOM tracks the Solactive Genomics Index ...

  • GuruFocus.com12 days ago

    Get 40% Annualized Returns With This Merger Arbitrage Stock

    Illumina Inc. is acquiring Pacific Biosciences for $8 per share in cash. Now trading at just $7.30 a piece, this looks like an attractive arbitrage opportunity

  • Biotechnology Market on a Tear: 5 ETFs in Spotlight
    Zacks13 days ago

    Biotechnology Market on a Tear: 5 ETFs in Spotlight

    Increasing M&A deals, growing AI dominance and favorable regulatory tidings continue to accelerate the biotech market. Accordingly, ETFs with exposure to the sector continue to shine.

  • Global X Launches GNOM ETF to Tap Booming Genomics Space
    Zacks14 days ago

    Global X Launches GNOM ETF to Tap Booming Genomics Space

    Having exposure to trending areas like Robotics & AI, e-commerce and IoT, Global X is set to gain from the booming genomics market with the GNOM ETF.

  • Business Wire15 days ago

    Illumina to Announce First Quarter 2019 Financial Results on Thursday, April 25, 2019

    Illumina, Inc. (ILMN) today announced that it will issue results for first quarter 2019 following the close of market on Thursday, April 25, 2019. On the same day, at 2:00 pm Pacific Time (5:00 pm Eastern Time) Francis deSouza, President and Chief Executive Officer, and Sam Samad, Senior Vice President and Chief Financial Officer, will host a conference call with analysts, investors, and other interested parties to discuss financial and operating results. Interested parties may access the live teleconference through the Investor Relations section of Illumina’s website under the “company” tab at www.illumina.com.

  • These Cannabis and China ETFs are Leading the 2019 Rally
    Investopedia15 days ago

    These Cannabis and China ETFs are Leading the 2019 Rally

    Stock investors seeking even bigger returns than the 2019 bull rally might look at five ETFs that have already gained at least 40% year-to-date, approaching triple the 15% pace of the S&P 500. The winners ...

  • Motley Fool15 days ago

    Why Vertex Pharmaceuticals Could Conceivably Succeed Too Well

    The sky is the limit for this biotech leader.

  • Markit15 days ago

    See what the IHS Markit Score report has to say about Illumina Inc.

    Illumina Inc NASDAQ/NGS:ILMNView full report here! Summary * ETFs holding this stock are seeing positive inflows * Bearish sentiment is low * Economic output in this company's sector is expanding Bearish sentimentShort interest | PositiveShort interest is low for ILMN with fewer than 5% of shares on loan. The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. Money flowETF/Index ownership | PositiveETF activity is positive. Over the last month, ETFs holding ILMN are favorable with net inflows of $113.61 billion. This was the highest net inflow seen over the last one-year.Error parsing the SmartText Economic sentimentPMI by IHS Markit | PositiveAccording to the latest IHS Markit Purchasing Managers' Index (PMI) data, output in the Healthcare sector is rising. The rate of growth is strong relative to the trend shown over the past year, and is accelerating. Credit worthinessCredit default swapCDS data is not available for this security.Please send all inquiries related to the report to score@ihsmarkit.com.Charts and report PDFs will only be available for 30 days after publishing.This document has been produced for information purposes only and is not to be relied upon or as construed as investment advice. To the fullest extent permitted by law, IHS Markit disclaims any responsibility or liability, whether in contract, tort (including, without limitation, negligence), equity or otherwise, for any loss or damage arising from any reliance on or the use of this material in any way. Please view the full legal disclaimer and methodology information on pages 2-3 of the full report.

  • Motley Fool15 days ago

    Why Illumina Could Be a Health Tech Powerhouse for Your Portfolio

    The sky is the limit for the leader in DNA sequencing.

  • Motley Fool15 days ago

    5 Stocks in the Age of Miracles

    Motley Fool co-founder David Gardner shares five picks that are changing the world and bringing tomorrow closer to today.

  • Medtronic's New Data for HVAD System to Boost CRHF Segment
    Zacks17 days ago

    Medtronic's New Data for HVAD System to Boost CRHF Segment

    Medtronic's (MDT) latest data is expected to boost top-line contributions from the HeartWare HVAD System within the CRHF suite.

  • 3 High-Growth Genomics Stocks You Can Buy
    Motley Fool18 days ago

    3 High-Growth Genomics Stocks You Can Buy

    These fast-growing companies are leveraging advances in genetic insight in ways that could pay off big for investors.

  • Myriad Genetics New Study Data to Lift Prenatal Tests' Uptake
    Zacks21 days ago

    Myriad Genetics New Study Data to Lift Prenatal Tests' Uptake

    The recent development will help Myriad Genetics (MYGN) to boost top-line contributions from prenatal tests.

  • Final Trades: Illumina, Baidu, Adient & Enterprise Products
    CNBC20 days ago

    Final Trades: Illumina, Baidu, Adient & Enterprise Products

    The "Halftime Report" traders give their top stocks to watch.